文献速递肿瘤 PET/CT

[18F]-FDG与[68Ga]-DOTA-FAPI-04 PET/CT对铂敏感复发性卵巢癌影像学评估的头对头比较

Head-to-head comparison of [18F]-FDG and [68 Ga]-DOTA-FAPI-04 PET/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancer.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-01-10

研究纳入2022年1月至7月29例疑似铂敏感复发性卵巢癌患者,在1周内先后行[18F]-FDG与[68Ga]-FAPI PET/CT。22例(75.86%)两种扫描结果不一致,5例(17.24%)因差异改变治疗策略。[68Ga]-FAPI PET检测复发病灶的灵敏度与准确率高于[18F]-FDG(96.30% vs 49.07%;97.40% vs 63.87%),视觉评分与Eisenkop评分也更高。

要点

  • 29例疑似铂敏感复发性卵巢癌中22例(75.86%)两种PET/CT结果不一致,5例(17.24%)因差异改变治疗策略。
  • [68Ga]-FAPI PET检测病灶灵敏度96.30%、准确率97.40%,高于[18F]-FDG的49.07%和63.87%。
  • [68Ga]-FAPI PET视觉评分41 vs [18F]-FDG 4,Eisenkop评分27 vs 16(p=0.025)。

核心结论

  • [68Ga]-FAPI在检测复发病灶方面优于[18F]-FDG PET/CT,对铂敏感复发性卵巢癌的个体化管理具有关键意义。

研究设计与样本

  • 2022年1月至7月纳入29例疑似铂敏感复发性卵巢癌患者,1周内完成[18F]-FDG与[68Ga]-FAPI PET/CT,记录治疗策略、视觉评分与Eisenkop评分,采用配对T检验比较两种扫描差异,并评估灵敏度、特异度、PPV、NPV和准确率。

主要发现

  • 22例(75.86%)患者两种扫描结果不一致,其中4例[18F]-FDG阴性而[68Ga]-FAPI显示可测量病灶;5例(17.24%)因差异改变治疗策略;15例(35.7%)接受手术,14例达到完全切除,1例有毫米级残留病灶;[68Ga]-FAPI复发病灶的TBR显著高于[18F]-FDG,但SUVmax无此差异;[68Ga]-FAPI PET灵敏度96.30% vs [18F]-FDG 49.07%,准确率97.40% vs 63.87%;视觉评分41 vs 4,腹膜转移35 vs 1;Eisenkop评分27 vs 16(p=0.025)。

关键数值与推荐

  • [68Ga]-FAPI PET检测病灶灵敏度96.30%,[18F]-FDG为49.07%。
  • [68Ga]-FAPI PET检测病灶准确率97.40%,[18F]-FDG为63.87%。
  • [68Ga]-FAPI PET视觉评分41,[18F]-FDG为4;腹膜转移视觉评分35 vs 1。
  • Eisenkop评分[68Ga]-FAPI 27 vs [18F]-FDG 16(p=0.025)。

临床怎么用

  • 作者认为[68Ga]-FAPI在检测复发病灶方面优于[18F]-FDG PET/CT,对铂敏感复发性卵巢癌的个体化管理具有关键意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Precise radiological evaluation is pivotal for the management of platinum-sensitive recurrent ovarian cancer. We aimed to compare the value of [68 Ga]-FAPI and [18F]-FDG PET/CT for the detection of relapsed lesions. METHODS: Twenty-nine suspected platinum-sensitive recurrent ovarian cancers were enrolled from January 2022 to July 2022. [18F]-FDG and [68 Ga]-FAPI PET/CT were obtained within 1 week for radiological evaluation. Treatment strategies, visual scores, and Eisenkop scores were recorded. A paired T test was used to compare differences between two scans. Sensitivity, specificity, PPV, NPV, and accuracy were also evaluated. RESULTS: Up to 22 (75.86%) patients displayed inconsistency between two scans. Among them, 4 patients with negative [18F]-FDG imaging had measurable lesions in [68 Ga]-FAPI scans. The treatment strategies were changed in 5 patients (17.24%) due to discrepancies. Finally, 15 (35.7%) patients underwent surgeries, and 14 patients achieved complete resection, except for 1 patient who had milliarc residual disease. TBR, but not SUVmax, of [68 Ga]-FAPI was significantly higher than that of [18F]-FDG in recurrent lesions. Compared with [18F]-FDG, [68 Ga]-FAPI PET presented higher sensitivity and accuracy for lesion detection (96.30% vs. 49.07% and 97.40% vs. 63.87%, respectively). Additionally, [68 Ga]-FAPI PET showed a much higher visual score than [18F]-FDG PET (41 vs. 4), especially for peritoneal metastasis (35 vs. 1). [68 Ga]-FAPI PET also presented a larger tumor burden than [18F]-FDG according to the Eisenkop score (27 vs. 16, p = 0.025). CONCLUSIONS: [68 Ga]-FAPI was superior to [18F]-FDG PET/CT for the detection of recurrent lesions, which is pivotal for the individualized management of platinum-sensitive recurrent ovarian cancer.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Liu S, Feng Z, Xu X, et al. Head-to-head comparison of [18F]-FDG and [68 Ga]-DOTA-FAPI-04 PET/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancer. Eur J Nucl Med Mol Imaging. 2023. PMID: 36624168. doi:10.1007/s00259-022-06096-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。